Patients' expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis.

被引：1
|
作者：
Belz, Aleksandra [1 ]
Debowska, Paulina [2 ]
Warzecha, Joanna [3 ]
Gasiorek, Aleksandra [4 ]
Galczynska, Dominika [4 ]
Czyz, Sylwia [4 ]
Ziaja, Bettina [4 ]
Jastrzebski, Dariusz [3 ]
Ziora, Dariusz [3 ]
机构：
[1] Publ Hosp Chorzow, Dept Internal Med, Chorzow, Poland
[2] Dept Geriatr, Katowice, Poland
[3] Med Univ Silesia, Dept Lung Dis & TB, Zabrze, Poland
[4] Med Univ Silesia, Zabrze, Poland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA4784
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4784
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pirfenidone treatment for patients with pulmonary fibrosis.
    Nagal, S
    Shigematsu, M
    Hamada, K
    Nagao, T
    Nio, T
    Ikeda, A
    Taniyama, M
    Izumi, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A53 - A53
  • [2] QUALITY OF LIFE AND ADVERSE EFFECTS IN PATIENTS TAKING PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS
    Capps, J.
    Amies, B.
    Duck, A.
    Frank, R.
    Leonard, C.
    Holme, J.
    THORAX, 2012, 67 : A120 - A120
  • [3] Longitudinal Changes in Quality of Life in Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in the PROOF Registry
    Wuyts, W.
    Dahlqvist, C.
    Slabbynck, H.
    Schlesser, M.
    Gusbin, N.
    Compere, C.
    Maddens, S.
    Kirchgaessler, K.
    Bartley, K.
    Bondue, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] Inhaled pirfenidone is associated with better quality of life scores in idiopathic pulmonary fibrosis
    Kim, G.
    Goldin, J.
    Woodhead, F.
    Thompson, C. N.
    Shaffer, M.
    Otto, K.
    Montgomery, B.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] EFFICACY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Inagaki, Ai
    Tsutsumi, Takeo
    Kuriyama, Sachiko
    Nagaoka, Tetsutaro
    Sekiya, Mitsuaki
    Morio, Yoshiteru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 135 - 135
  • [6] Development of a Disease Specific Health Related Quality of Life Instrument for Patients with Idiopathic Pulmonary Fibrosis.
    Vallejo, S. L.
    Sahn, S. A.
    Ford, D. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] Expectations, symptoms, and quality of life before and after 1 year of Pirfenidone treatment in patients with idiopathic pulmonary fibrosis: A single-arm, open-label nonrandomized study
    Jastrzebski, Dariusz
    Kostorz-Nosal, Sabina
    Galle, Dagmara
    Galeczka-Turkiewicz, Alicja
    Warzecha, Joanna
    Majewski, Sebastian
    Piotrowski, Wojciech J.
    Ziora, Dariusz
    HEALTH SCIENCE REPORTS, 2023, 6 (08)
  • [8] Effectiveness and safety of pirfenidone used for treatment of idiopathic pulmonary fibrosis
    Gonzalez Sevilla, Marta
    Garcia Munoz, Carmen
    Ortiz Perez, Sara
    Lazaro Cebas, Andrea
    Fernandez Redondo, Delia
    Serrano Garrote, Olga
    Ferrari Piquero, Jose Miguel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 327 - 327
  • [9] Quality of life of idiopathic pulmonary fibrosis patients
    De Vries, J
    Kessels, BLJ
    Drent, M
    EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (05) : 954 - 961
  • [10] Pirfenidone in idiopathic pulmonary fibrosis
    Swigris, J.
    Fairclough, D.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 695 - 696
12345